Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Journal of Health Management
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chaudhury, R. R.
Right arrow Articles by Gurbani, N.K.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The TRIPS Agreement: Implications for Access to Drugs in Developing Countries

Ranjit Roy Chaudhury

N.K. Gurbani

Globalisation will have an adverse effect on access to drugs as far as developing countries are concerned because when the Trade Related Intellectual Property Rights (TRIPS) Agreement comes into operation in 2005 the prices of drugs for which patents are in place will increase. However, this effect can be reduced if timely steps are taken to aggressively introduce programmes of rational use of drugs and the country enacts legislation to take advantage of the possible safe guards that have been incorporated into the TRIPS Agreement.

Journal of Health Management, Vol. 4, No. 1, 11-18 (2002)
DOI: 10.1177/097206340200400102
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?